Lv1
30 积分 2025-08-27 加入
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
9小时前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
9小时前
已完结
Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease
5天前
已完结
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms
29天前
已完结
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
29天前
已完结
Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance
29天前
已完结
Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia
1个月前
已完结
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial
1个月前
已完结
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease
1个月前
已完结
Drug and Sociotherapy in the Aftercare of Schizophrenic Patients
1个月前
已完结
皖公网安备34019202002308
